Pharmacoeconomic analysis of Capecitabine in the adjuvant setting. Results from the X-ACT trial comparing capecitabine with 5-FU/LV in patients with Dukes' C colon cancer - Douillard, J; Twelves, C; McKendrick, J; Bertetto, O; Coxon, F; Diaz-Rubio, E; Dufour, P; Maughan, T; Scheithauer, W; Burris, H (2004)